DarioHealth (NASDAQ: DRIO) president and North America general manager Rick Anderson will present at this year’s Vatican conference; the conference will be virtual this year. The Vatican’s Pontifical Council for Culture and the Cura Foundation’s Fifth International Vatican Conference is designed to globally advance human health by bringing together physicians, scientists, patient advocates, policy makers and other influential leaders from around the world. During the conference, which will be held May 6–8, 2021, participants discuss the latest breakthroughs in medicine, health care delivery and prevention. Anderson will be a featured presenter on the conference’s Insight and Perspectives track, as he discusses how technology can be used to support sustained behavior change and improve the health of people managing chronic diseases. DRIO is a pioneer in the global digital therapeutics market. Other conference speakers are Dr. Anthony S. Fauci, director of the National Institute of Allergy and Infectious Diseases; Dr. Jane Goodall, founder of the Jane Goodall Institute and UN messenger of peace; and Jo Ann Jenkins, AARP CEO, and many others. Of particular interest is this year’s plan to launch a global #UnitedToPrevent campaign focused on the theme of Exploring the Mind, Body & Soul. The campaign will examine how innovations and novel delivery systems improve human health. “Technology available today offers a powerful alternative that combines the benefits of AI-based dynamic personalization, biofeedback and a digital delivery platform with the human touch and personal support people need to establish sustained behavior change,” said DarioHealth president and North America general manager Rick Anderson in the press release. “Digital therapeutic tools can provide greater health equity and access through asynchronous distributed care.”
To attend the conference, visit https://ibn.fm/UaTyU
To view the full press release, visit https://ibn.fm/rUlPO
About DarioHealth Corp.
DarioHealth Corp. is a leading global digital therapeutics company revolutionizing how people with chronic conditions manage their health. Dario’s next-generation, AI-powered, digital therapeutic solutions support more than just an individual’s disease. Dario provides adaptive, personalized experiences that drive behavior change through evidence-based interventions, intuitive, clinically proven digital tools, high-quality software and coaching to help individuals improve health and sustain meaningful outcomes. Dario offers one of the highest-rated diabetes and hypertension solutions on the market. The company’s cross-functional team operates at the intersection of life sciences, behavioral science, and software technology and is rapidly expanding into new chronic conditions and geographic markets, using a performance-based approach to improve its users’ health. Dario makes the right thing to do the easy thing to do. For more information about the company, please visit www.DarioHealth.com.
NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at http://ibn.fm/DRIO
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
